報價延遲最少15分鐘:2025/01/21 08:46 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.46/--
|
|
企業價值
98.39M
|
| 資產負債 |
|
每股賬面淨值
1.96
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
42.16M
|
|
每股收益
3.29
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:46 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the useof a PID kit. |